BACITRACIN ZINC AND POLYMYXIN B SULFATE

BACITRACIN ZINC AND POLYMYXIN B SULFATE was reported 111 times

BACITRACIN ZINC AND POLYMYXIN B SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CORNEAL GRAFT FAILURE 1 0.0435
1 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
2 BEREAVEMENT 1 0.0217
3 EYE ABRASION 1 0.0189
4 LUNG ASSIST DEVICE THERAPY 1 0.0161
5 INTENTIONAL REMOVAL OF DRUG DELIVERY SYSTEM BY PATIENT 1 0.0154
6 ACANTHOLYSIS 1 0.0152
7 ASTHMA LATE ONSET 1 0.0116
8 CRANIAL NERVE INJURY 1 0.0103
9 VAGINAL FLATULENCE 3 0.0099
10 BURKHOLDERIA TEST POSITIVE 1 0.0081
11 SPINDLE CELL SARCOMA 1 0.0074
12 TRICHOMONIASIS 1 0.0069
13 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
14 LIPOSUCTION 1 0.0065
15 WOUND DECOMPOSITION 1 0.0060
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
17 INSTILLATION SITE SWELLING 1 0.0057
18 CORNEAL INFECTION 1 0.0046
19 SERONEGATIVE ARTHRITIS 5 0.0044
20 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 1 0.0043
21 INSTILLATION SITE LACRIMATION 1 0.0041
22 OBSESSIVE-COMPULSIVE PERSONALITY DISORDER 1 0.0040
23 EYE INFECTION VIRAL 1 0.0031
24 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
25 INSTILLATION SITE PRURITUS 1 0.0027
26 DISLOCATION OF VERTEBRA 6 0.0026
27 EYE INFECTION FUNGAL 1 0.0026
28 DEEP VEIN THROMBOSIS POSTOPERATIVE 5 0.0025
29 AMMONIA ABNORMAL 1 0.0025
30 LUPUS VULGARIS 3 0.0024
31 FEMALE GENITAL TRACT FISTULA 4 0.0023
32 DIVORCED 1 0.0023
33 SPINAL FUSION SURGERY 9 0.0022
34 INFUSION SITE HAEMATOMA 1 0.0021
35 TYPE V HYPERLIPIDAEMIA 1 0.0021
36 MARITAL PROBLEM 1 0.0019
37 BACTERIURIA 1 0.0018
38 RETINITIS 3 0.0017
39 BONE EROSION 5 0.0014
40 MONOCYTE PERCENTAGE INCREASED 1 0.0014
41 ACCOMMODATION DISORDER 1 0.0014
42 BLUNTED AFFECT 1 0.0014
43 SWOLLEN JOINT COUNT INCREASED 4 0.0013
44 WALKING AID USER 8 0.0012
45 INCISION SITE COMPLICATION 1 0.0012
46 WOUND INFECTION 13 0.0012
47 PERIORBITAL PAIN 1 0.0012
48 RADICULOPATHY 3 0.0011
49 CEREBELLAR ATROPHY 1 0.0011
50 JAW OPERATION 1 0.0011
51 SPONDYLITIS 4 0.0011
52 PROCTITIS 3 0.0011
53 CHRONIC SINUSITIS 4 0.0011
54 CEREBELLAR ATAXIA 1 0.0010
55 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
56 TINEA INFECTION 1 0.0009
57 RHEUMATIC FEVER 4 0.0009
58 PRURITUS ALLERGIC 1 0.0009
59 INCISION SITE PAIN 1 0.0009
60 INSTILLATION SITE IRRITATION 1 0.0008
61 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
62 INSTILLATION SITE PAIN 2 0.0008
63 INFUSION SITE IRRITATION 1 0.0008
64 APPLICATION SITE EROSION 1 0.0008
65 BREAST CANCER STAGE III 5 0.0008
66 CORNEAL ABRASION 1 0.0007
67 IMMUNOGLOBULINS DECREASED 1 0.0007
68 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5 0.0007
69 RHEUMATOID FACTOR POSITIVE 4 0.0007
70 GRIP STRENGTH DECREASED 6 0.0007
71 CONJUNCTIVITIS ALLERGIC 1 0.0007
72 DUODENAL ULCER PERFORATION 5 0.0007
73 INFERTILITY 1 0.0007
74 EYE ALLERGY 1 0.0006
75 BACTERIAL VAGINOSIS 1 0.0006
76 TINEA PEDIS 1 0.0006
77 SKIN WOUND 1 0.0006
78 PNEUMOMEDIASTINUM 1 0.0006
79 EXOSTOSIS 5 0.0005
80 FOOT DEFORMITY 6 0.0005
81 HIP ARTHROPLASTY 8 0.0005
82 AUTOIMMUNE DISORDER 5 0.0005
83 MUSCLE INJURY 4 0.0005
84 SWELLING OF EYELID 3 0.0005
85 EYE CONTUSION 1 0.0005
86 HAND DEFORMITY 6 0.0005
87 BIPOLAR I DISORDER 1 0.0005
88 LUPUS-LIKE SYNDROME 4 0.0004
89 WOUND 12 0.0004
90 PUSTULE 1 0.0004
91 MYOPIA 1 0.0004
92 HYPERCHOLESTEROLAEMIA 4 0.0004
93 PEMPHIGUS 5 0.0004
94 CATHETER SITE HAEMORRHAGE 1 0.0004
95 VAGINAL DISCHARGE 4 0.0004
96 RETINAL DISORDER 1 0.0004
97 FOLLICULITIS 4 0.0004
98 JOINT DISLOCATION 4 0.0004
99 ANIMAL BITE 1 0.0004
100 GAMBLING DISORDER 1 0.0004
101 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
102 ENDOTRACHEAL INTUBATION 1 0.0004
103 DRUG TOLERANCE DECREASED 1 0.0004
104 MACULAR DEGENERATION 4 0.0003
105 SYNOVITIS 6 0.0003
106 EYE INJURY 1 0.0003
107 KERATITIS 1 0.0003
108 FOREIGN BODY SENSATION IN EYES 2 0.0003
109 PRESCRIBED UNDERDOSE 6 0.0003
110 JOINT RANGE OF MOTION DECREASED 4 0.0003
111 PERICARDITIS 5 0.0003
112 HELICOBACTER INFECTION 3 0.0003
113 MONOCYTE COUNT INCREASED 1 0.0003
114 GLOSSODYNIA 6 0.0003
115 IMPULSIVE BEHAVIOUR 1 0.0003
116 PULMONARY FIBROSIS 5 0.0003
117 PRESCRIBED OVERDOSE 5 0.0003
118 EYELID OEDEMA 3 0.0003
119 WOUND SECRETION 1 0.0003
120 PROSTATOMEGALY 1 0.0003
121 SCIATICA 4 0.0003
122 FIBROMYALGIA 6 0.0002
123 RECURRENT CANCER 1 0.0002
124 APPLICATION SITE EXFOLIATION 1 0.0002
125 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
126 PURULENT DISCHARGE 1 0.0002
127 ORAL CANDIDIASIS 3 0.0002
128 RHINITIS ALLERGIC 1 0.0002
129 WHEEZING 13 0.0002
130 HEPATIC CIRRHOSIS 4 0.0002
131 VAGINAL INFECTION 1 0.0002
132 SKIN ABRASION 1 0.0002
133 LOWER LIMB FRACTURE 4 0.0002
134 PARAESTHESIA ORAL 3 0.0002
135 LIVER INJURY 5 0.0002
136 APPLICATION SITE SWELLING 1 0.0002
137 POOR VENOUS ACCESS 2 0.0002
138 EYE DISCHARGE 2 0.0002
139 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
140 IRRITABLE BOWEL SYNDROME 4 0.0002
141 LIVER FUNCTION TEST INCREASED 4 0.0002
142 ASTHENOPIA 1 0.0002
143 HYPERKERATOSIS 1 0.0002
144 TYPE 2 DIABETES MELLITUS 6 0.0002
145 EYE INFECTION 2 0.0002
146 PERIORBITAL SWELLING 1 0.0002
147 DELIRIUM 6 0.0002
148 HYPERVENTILATION 1 0.0002
149 CATARACT OPERATION 1 0.0002
150 PLEURISY 1 0.0002
151 INFUSION SITE EXTRAVASATION 1 0.0002
152 DRUG-INDUCED LIVER INJURY 5 0.0002
153 INFUSION SITE SWELLING 1 0.0002
154 SCREAMING 1 0.0002
155 HERPES SIMPLEX 1 0.0002
156 JOINT STIFFNESS 4 0.0002
157 IMPAIRED HEALING 5 0.0002
158 DISABILITY 3 0.0002
159 PRODUCT FORMULATION ISSUE 1 0.0002
160 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
161 EAR INFECTION 4 0.0002
162 GAIT INABILITY 5 0.0001
163 POST-TRAUMATIC STRESS DISORDER 1 0.0001
164 FREQUENT BOWEL MOVEMENTS 4 0.0001
165 PROCEDURAL PAIN 4 0.0001
166 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
167 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
168 C-REACTIVE PROTEIN INCREASED 5 0.0001
169 UTERINE LEIOMYOMA 1 0.0001
170 HYPOPHOSPHATAEMIA 1 0.0001
171 ARTHROPOD BITE 1 0.0001
172 LACRIMATION INCREASED 4 0.0001
173 ATRIOVENTRICULAR BLOCK 1 0.0001
174 CONCUSSION 1 0.0001
175 BLOOD CHOLESTEROL INCREASED 6 0.0001
176 BLISTER 7 0.0001
177 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
178 PSORIATIC ARTHROPATHY 5 0.0001
179 AMNESIA 8 0.0001
180 INFUSION RELATED REACTION 8 0.0001
181 HAEMODIALYSIS 1 0.0001
182 FACIAL PARALYSIS 1 0.0001
183 MUSCLE STRAIN 1 0.0001
184 SPINAL OSTEOARTHRITIS 1 0.0001
185 ARTHROPATHY 6 0.0001
186 COLITIS 4 0.0001
187 OCULAR HYPERAEMIA 5 0.0001
188 THERAPY CHANGE 1 0.0001
189 DYSPEPSIA 10 0.0001
190 LIGAMENT SPRAIN 1 0.0001
191 DISCOMFORT 6 0.0001
192 MOTOR DYSFUNCTION 1 0.0001
193 NEUTROPHIL COUNT INCREASED 1 0.0001
194 OSTEOPOROSIS 4 0.0001
195 SWELLING 9 0.0001
196 ROAD TRAFFIC ACCIDENT 4 0.0001
197 SCRATCH 1 0.0001
198 OSTEOARTHRITIS 4 0.0001
199 OEDEMA 5 0.0001
200 SKIN LACERATION 1 0.0001
201 APPLICATION SITE PAIN 2 0.0001
202 COLITIS ULCERATIVE 4 0.0001
203 DERMATITIS CONTACT 1 0.0001
204 MICTURITION URGENCY 1 0.0001
205 POST PROCEDURAL HAEMORRHAGE 1 0.0001
206 BACTERAEMIA 1 0.0001
207 STOMATITIS 5 0.0001
208 EYE SWELLING 3 0.0001
209 APPLICATION SITE IRRITATION 1 0.0001
210 APPLICATION SITE ERYTHEMA 2 0.0001
211 DYSMENORRHOEA 1 0.0001
212 ADVERSE REACTION 1 0.0001
213 PRODUCT TASTE ABNORMAL 1 0.0001
214 BLINDNESS 3 0.0001
215 TACHYPNOEA 1 0.0001
216 IMPAIRED GASTRIC EMPTYING 1 0.0001
217 ACUTE HEPATIC FAILURE 1 0.0001
218 PERIPHERAL COLDNESS 1 0.0001
219 COORDINATION ABNORMAL 1 0.0001
220 EYE PAIN 4 0.0001
221 SEASONAL ALLERGY 1 0.0001
222 RECTAL HAEMORRHAGE 3 0.0001
223 MOBILITY DECREASED 5 0.0001
224 WEIGHT INCREASED 15 0.0001
225 ECONOMIC PROBLEM 1 0.0001
226 VISUAL IMPAIRMENT 8 0.0001
227 LUNG INFECTION 1 0.0001
228 ACUTE MYELOID LEUKAEMIA 1 0.0001
229 BRAIN FOG 1 0.0001
230 ARTHRITIS 5 0.0001
231 HALLUCINATION, AUDITORY 1 0.0001
232 OBESITY 1 0.0001
233 CONTUSION 6 0.0001
234 EYE DISORDER 2 0.0001
235 STAPHYLOCOCCAL INFECTION 2 0.0001
236 EYE PRURITUS 2 0.0001
237 HYPERSENSITIVITY 11 0.0001
238 CANDIDA INFECTION 1 0.0001
239 HEPATIC ENZYME INCREASED 4 0.0001
240 INJURY 4 0.0001
241 SLEEP DISORDER 4 0.0001
242 LYMPHOCYTE COUNT DECREASED 1 0.0001
243 TACHYCARDIA 5 0.0001
244 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
245 HAEMATOCHEZIA 3 0.0001
246 BRONCHITIS 4 0.0001
247 CONJUNCTIVITIS 1 0.0001
248 ASTHMA 6 0.0001
249 BLOOD SODIUM DECREASED 1 0.0001
250 MUSCULAR WEAKNESS 6 0.0001
251 EYE IRRITATION 3 0.0001
252 ORAL HERPES 1 0.0001
253 HAEMATOCRIT DECREASED 1 0.0001
254 CHEST PAIN 9 0.0000
255 URTICARIA 8 0.0000
256 HALLUCINATION, VISUAL 1 0.0000
257 RETCHING 1 0.0000
258 SKIN CANCER 1 0.0000
259 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
260 PRODUCT PRESCRIBING ISSUE 1 0.0000
261 MUSCULOSKELETAL STIFFNESS 4 0.0000
262 TOOTH DISORDER 1 0.0000
263 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
264 HEART RATE IRREGULAR 1 0.0000
265 APPLICATION SITE PRURITUS 1 0.0000
266 RHEUMATOID ARTHRITIS 5 0.0000
267 PRODUCT AVAILABILITY ISSUE 1 0.0000
268 MEMORY IMPAIRMENT 6 0.0000
269 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
270 RASH ERYTHEMATOUS 2 0.0000
271 JOINT SWELLING 5 0.0000
272 MENTAL IMPAIRMENT 1 0.0000
273 OEDEMA PERIPHERAL 5 0.0000
274 WEIGHT DECREASED 11 0.0000
275 SKIN ULCER 1 0.0000
276 RESPIRATORY TRACT INFECTION 1 0.0000
277 ANHEDONIA 1 0.0000
278 THROAT TIGHTNESS 1 0.0000
279 PNEUMONITIS 1 0.0000
280 ABDOMINAL DISCOMFORT 6 0.0000
281 ALOPECIA 7 0.0000
282 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
283 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
284 RED BLOOD CELL COUNT DECREASED 1 0.0000
285 HYPERSOMNIA 1 0.0000
286 INFECTION 5 0.0000
287 NASAL CONGESTION 2 0.0000
288 PSYCHOTIC DISORDER 1 0.0000
289 URINARY INCONTINENCE 1 0.0000
290 RESPIRATORY DISORDER 1 0.0000
291 HYPOAESTHESIA 5 0.0000
292 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
293 CONDITION AGGRAVATED 10 0.0000
294 PERIPHERAL SWELLING 5 0.0000
295 HEAD INJURY 1 0.0000
296 CYSTITIS 1 0.0000
297 GAIT DISTURBANCE 6 0.0000
298 PRURITUS 12 0.0000
299 NIGHT SWEATS 1 0.0000
300 CONFUSIONAL STATE 5 0.0000
301 PSORIASIS 4 0.0000
302 DECREASED APPETITE 7 0.0000
303 SINUSITIS 3 0.0000
304 ERYTHEMA 6 0.0000
305 GASTRIC DISORDER 1 0.0000
306 RASH MACULAR 1 0.0000
307 HEART RATE DECREASED 1 0.0000
308 HYPERTENSION 6 0.0000
309 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
310 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
311 HYPERGLYCAEMIA 1 0.0000
312 RESPIRATORY FAILURE 2 0.0000
313 UNDERDOSE 2 0.0000
314 DYSURIA 1 0.0000
315 DYSARTHRIA 1 0.0000
316 DEPRESSION 6 0.0000
317 ANAEMIA 5 0.0000
318 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
319 PYREXIA 9 0.0000
320 RASH 11 0.0000
321 DYSKINESIA 1 0.0000
322 ANXIETY 7 0.0000
323 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
324 SKIN EXFOLIATION 2 0.0000
325 RENAL FAILURE ACUTE 1 0.0000
326 URINARY TRACT INFECTION 4 0.0000
327 MENTAL DISORDER 1 0.0000
328 CONSTIPATION 5 0.0000
329 DEVICE ISSUE 2 0.0000
330 VISION BLURRED 3 0.0000
331 NASOPHARYNGITIS 4 0.0000
332 ABDOMINAL PAIN 5 0.0000
333 DYSPHAGIA 2 0.0000
334 PRODUCTIVE COUGH 1 0.0000
335 BLOOD GLUCOSE DECREASED 1 0.0000
336 HEADACHE 13 0.0000
337 LUNG DISORDER 1 0.0000
338 AGGRESSION 1 0.0000
339 PAIN 12 0.0000
340 ILLNESS 2 0.0000
341 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
342 BRADYCARDIA 1 0.0000
343 RASH PRURITIC 1 0.0000
344 TREATMENT NONCOMPLIANCE 1 0.0000
345 ANAPHYLACTIC REACTION 1 0.0000
346 DIZZINESS 9 0.0000
347 SEPSIS 2 0.0000
348 OXYGEN SATURATION DECREASED 1 0.0000
349 DYSPNOEA 10 0.0000
350 HERPES ZOSTER 1 0.0000
351 OFF LABEL USE 15 0.0000
352 VOMITING 8 0.0000
353 PAIN IN EXTREMITY 5 0.0000
354 NO ADVERSE EVENT 3 0.0000
355 EMOTIONAL DISTRESS 2 0.0000
356 RHINORRHOEA 1 0.0000
357 SWELLING FACE 1 0.0000
358 BLOOD CREATININE INCREASED 1 0.0000
359 BLOOD PRESSURE DECREASED 1 0.0000
360 INSOMNIA 4 0.0000
361 PRODUCT QUALITY ISSUE 2 0.0000
362 ARTHRALGIA 6 0.0000
363 SKIN BURNING SENSATION 1 0.0000
364 DIARRHOEA 9 0.0000
365 NAUSEA 11 0.0000
366 AGITATION 1 0.0000
367 EPISTAXIS 1 0.0000
368 UNEVALUABLE EVENT 1 0.0000
369 CHRONIC KIDNEY DISEASE 1 0.0000
370 DIABETES MELLITUS 1 0.0000
371 INJECTION SITE SWELLING 1 0.0000
372 CARDIAC FAILURE CONGESTIVE 1 0.0000
373 THROMBOSIS 1 0.0000
374 PNEUMONIA 4 0.0000
375 INFLUENZA LIKE ILLNESS 1 0.0000
376 TREATMENT FAILURE 1 0.0000
377 RENAL IMPAIRMENT 1 0.0000
378 BALANCE DISORDER 1 0.0000
379 FATIGUE 9 0.0000
380 INTENTIONAL PRODUCT MISUSE 1 0.0000
381 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
382 GASTROINTESTINAL DISORDER 1 0.0000
383 SUICIDAL IDEATION 1 0.0000
384 BREAST CANCER 1 0.0000
385 COUGH 3 0.0000
386 PRODUCT USE ISSUE 2 0.0000
387 NEUROPATHY PERIPHERAL 1 0.0000
388 DRUG INTOLERANCE 1 0.0000
389 HEART RATE INCREASED 1 0.0000
390 HYPOTENSION 2 0.0000
391 CHEST DISCOMFORT 1 0.0000
392 HAEMOGLOBIN DECREASED 1 0.0000
393 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
394 MALAISE 4 0.0000
395 FALL 3 0.0000
396 INFLUENZA 1 0.0000
397 BACK PAIN 2 0.0000
398 PALPITATIONS 1 0.0000
399 INJECTION SITE ERYTHEMA 1 0.0000
400 ASTHENIA 3 0.0000
401 RENAL FAILURE 1 0.0000
402 DEHYDRATION 1 0.0000
403 DRY SKIN 1 0.0000
404 PRODUCT DOSE OMISSION ISSUE 2 0.0000
405 BLOOD PRESSURE INCREASED 1 0.0000
406 ACUTE KIDNEY INJURY 1 0.0000
407 HOSPITALISATION 1 0.0000
408 TREMOR 1 0.0000
409 TOXICITY TO VARIOUS AGENTS 1 0.0000
410 COVID-19 1 0.0000
411 DRUG INEFFECTIVE 7 0.0000
412 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
413 FEELING ABNORMAL 1 0.0000
414 INJECTION SITE PAIN 1 0.0000
415 DEATH 1 0.0000